Changes in Beneficial Ownership · 4
GLOBUS MEDICAL INC
GMEDNYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-15
- Issuer
- GLOBUS MEDICAL INC
- Issuer CIK
- 0001237831
- Trading symbol
- GMED
Reporting owner 1
- Name
- TOBIN JAMES R
- Reporting owner CIK
- 0001190128
- Relationship
- Director
- Address
- VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | 2026-09-15 | M · Form 4 | 15,000 | A | 53.75 | 15,000 | D |
| Class A Common Stock | 2026-09-15 | M · Form 4 | 15,000 | A | 63.68 | 30,000 | D |
| Class A Common Stock | 2026-09-15 | S · Form 4 | 30,000 | D | 74.5834[F1] | 0 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock) | 53.75 | 2026-09-15 | M · Form 4 | 15,000 | D | 0 | [F2] | 2034-01-26 | Class A Common Stock | 15,000 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock) | 63.68 | 2026-09-15 | M · Form 4 | 15,000 | D | 0 | [F3] | 2032-01-27 | Class A Common Stock | 15,000 | 0 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
- F1
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.33 to $74.96, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.↩ 1
- F2
- These options were granted on January 26, 2024 and are fully vested.↩ 1
- F3
- These options were granted on January 27, 2022 and are fully vested.↩ 1
Signature 1
- Signed
- /s/ Kelly G. Huller, Attorney-in-Fact
- Date
- 2026-09-16
Company context
Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com.